Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)

Memorial Sloan Kettering Cancer Center, New York

Roswell Park Cancer Institute, Buffalo

St Luke's University Health Network, Easton

University of Maryland, Marlene and Stewart Greenbaum Cancer Center, Baltimore

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

The University of North Carolina at Chapel Hill, Chapel Hill

Emory University, Atlanta

Sarah Cannon Research Institute, Nashville

Vanderbilt University Medical Center, Nashville

Yale University, New Haven

Dana Farber Cancer Institution, Boston